Pfizer Acquires Seagen Inc – Pfizer Invests $43bn to Battle Cancer

Pfizer Acquires Seagen

have announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a pioneer in antibody drug conjugate technology is called ADC, which is rapidly emerging as a powerful tool in cancer treatment.

Executive Summary

Deal Overview

Company Overview – Seagen

Company Overview – Pfizer

No of Pages: 79

To view another Acquisition report click here

Follow our LinkedIn page for more updates